Is peroral endoscopic myotomy the new gold standard for achalasia therapy?

Dig Endosc. 2023 Jan;35(2):173-183. doi: 10.1111/den.14477. Epub 2022 Dec 27.

Abstract

Our review focuses on critical analysis of the literature to determine whether peroral endoscopic myotomy (POEM) is poised to replace laparoscopic Heller myotomy (LHM) as the new "gold standard" for achalasia therapy. POEM matches or exceeds the efficacy of LHM. The difference in objective gastroesophageal reflux disease (GERD) between POEM and LHM is modest at best and dissipates with time. Post-POEM GERD can be easily managed medically in most patients without long-term GERD sequelae or the need for surgical fundoplication. Emerging POEM technique modifications can further decrease GERD. Endoscopic antireflux procedures such as transoral incisionless fundoplication (TIF) or POEM + F (POEM + fundoplication) can be used in the rare cases of medication-refractory GERD, but their long-term efficacy remains in question. In this comprehensive review, we summarize the current status of POEM with emphasis on GERD evaluation, prevention, treatment, and comparative data vs. LHM. Based on this analysis, it appears that POEM is indeed the new gold standard in the therapy of achalasia.

Keywords: GERD; NOTES; POEM; esophageal achalasia; laparoscopic Heller myotomy.

Publication types

  • Review

MeSH terms

  • Esophageal Achalasia* / surgery
  • Gastroesophageal Reflux / surgery
  • Heller Myotomy
  • Humans
  • Natural Orifice Endoscopic Surgery* / methods
  • Treatment Outcome